Instituto Valenciano de Oncologia-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2024

  1. Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation

    Molecular Cancer, Vol. 23, Núm. 1

2021

  1. Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer

    Clinical and Translational Oncology, Vol. 23, Núm. 7, pp. 1272-1280

2017

  1. Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes

    Cancer Letters, Vol. 409, pp. 42-48

2003

  1. Chemotherapy and concurrent hyperfractionated radiotherapy for patients with limited small-cell lung cancer: Long term results from a single institution and a review of the literature

    Oncologia, Vol. 26, Núm. 9, pp. 27-36